Antigenic variations in the CD4 induced sites of the CCR5-tropic, pathogenic SHIVsf162p3 gp120 variants

• Published in: Journal of medical primatology Vol. 32; no. 4-5; pp. 211 - 217
• Main Authors: Hsu, M., Buckner, C., Harouse, J., Gettie, A., Blanchard, J., Robinson, J.E., Cheng-Mayer, C.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Munksgaard International Publishers 01-08-2003
• Subjects: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigenic Variation; antigenicity; Blotting, Western; CCR5; CD4 Antigens - genetics; clones; envelope; Enzyme-Linked Immunosorbent Assay; HIV - genetics; HIV - immunology; HIV Envelope Protein gp120 - genetics; Humans; Luciferases; Molecular Sequence Data; Receptors, CCR5 - immunology; SHIV; Simian Immunodeficiency Virus - genetics; Simian Immunodeficiency Virus - immunology
• ISSN: 0047-2565; 1600-0684
• DOI: 10.1034/j.1600-0684.2003.00027.x

: In vivo passage of non‐pathogenic, CCR5‐tropic simian/human immunodeficiency virus (SHIV) – SHIVsf162 resulted in a pathogenic isolate, SHIVsf162p3. In an attempt to characterize envelope (Env)‐mediated properties that may contribute to its pathogenicity, major (P3 major) and minor (P3 minor) Env gp120 variants were cloned from the plasma of a SHIVsf162p3‐infected animal, and expressed in the context of luciferase reporter viruses. Entry mediated by these envelopes and susceptibility to neutralization by CD4 induced‐site (CD4i) antibodies (MAbs) was analyzed in comparison to parental SF162. Sequence analysis revealed that the P3 major and minor variant Envs contained 14 and 17 amino acid changes, respectively, compared with SF162. The rank order of entry mediated by the three envelopes was P3 major > SF162 > P3 minor, whereas the reverse order was observed for susceptibility to neutralization by CD4i MAbs. Since CD4i epitopes overlap the coreceptor (CoR) binding site, these findings suggest that the amino acid changes accumulated upon in vivo passage of SHIVsf162 result in Env gp120 structural rearrangements that modulate the exposure and/or conformation of the CoR binding site. This, in turn, led to increased entry and infectivity of the P3 major variant and may be responsible, in part, for the enhanced pathogenicity of SHIVsf162p3.